Premium
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review
Author(s) -
MEO A.,
CASSINERIO E.,
CASTELLI R.,
BIGNAMINI D.,
PEREGO L.,
CAPPELLINI M. D.
Publication year - 2008
Publication title -
international journal of laboratory hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 55
eISSN - 1751-553X
pISSN - 1751-5521
DOI - 10.1111/j.1751-553x.2007.00965.x
Subject(s) - polycythaemia , medicine , extramedullary hematopoiesis , bone marrow , myeloid , hydroxycarbamide , myelofibrosis , polycythemia vera , gastroenterology , haematopoiesis , pathology , metaplasia , stem cell , chemotherapy , biology , genetics
Summary Extramedullary haematopoiesis (EH) is the production of blood cell precursors outside the bone marrow that occurs in various disorders, such as thalassaemia, sickle cell anaemia, hereditary spherocytosis, polycythaemia vera, myelofibrosis and other haematological diseases. In chronic anaemia, it is a physiological response to increased erythropoietin. In some other conditions, such as myeloid metaplasia, polycythaemia vera or chronic myeloid leukaemia, EH is due to a clonal disorder of haematopoiesis that enables progenitor cells to escape from the marrow and lodge in other organs. EH usually involves the liver, spleen and lymph nodes or it can be paravertebral, intrathoracic, pelvic. It is often asymptomatic but can sometimes lead to symptomatic tumour‐like masses. Treatment options are still controversial and limited, including hypertransfusion regimen, surgical treatment, radiotherapy and hydroxyurea (HU). We describe intrathoracic and symptomatic pelvic EH masses in a 48‐year‐old woman and intrathoracic bilateral masses causing respiratory insufficiency with pleural effusion in a 42‐year‐old male, both affected by thalassaemia intermedia. Both patients showed a clinical improvement with hydroxyurea therapy and occasional blood transfusions.